Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2023 | R33 | CA278469 | RFA-CA-22-002 | JI, HANLEE P | STANFORD UNIVERSITY | Single cell modeling of cancer mutations | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2022 | R21 | CA257942 | CA21-003 | GIBBS, SUMMER LYNNE | OREGON HEALTH & SCIENCE UNIVERSITY | A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors | Active |
2021 | R21 | CA236665 | RFA-CA-20-019 | SANTORE, MARIA M | UNIVERSITY OF MASSACHUSETTS AMHERST | Paper-based Breastmilk Collection System for Facile, In-Home Use | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2023 | R33 | CA281602 | RFA-CA-22-002 | MEYER, KATHRYN D | DUKE UNIVERSITY | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors | Active |
2022 | R21 | CA250999 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Aliquot-level visual indicators of biospecimen exposure to thawed conditions | Active |
2021 | R21 | CA247647 | RFA-CA-20-017 | WILSON, GERALD M | UNIVERSITY OF MARYLAND BALTIMORE | Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases | Active |
2022 | R33 | CA272357 | RFA-CA-21-004 | PAN, TAO | UNIVERSITY OF CHICAGO | Transfer RNA sequencing and application to cancer research and clinics | Active |
2022 | R33 | CA272321 | RFA-CA-21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
2022 | R21 | CA257864 | CA21-003 | BOYLE, ALAN P | UNIVERSITY OF MICHIGAN AT ANN ARBOR | High-throughput inverted reporter assay for characterization of silencers and enhancer blockers | Active |
2021 | R21 | CA250597 | RFA-CA-20-017 | ZHANG, FANGLIANG | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) | Active |
2023 | R61 | CA278559 | RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis | Active |
2022 | R21 | CA261643 | RFA-CA-21-005 | TANG, SINDY KAM-YAN | STANFORD UNIVERSITY | A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy | Active |
2022 | R21 | CA258008 | CA21-003 | SCARCELLI, GIULIANO | UNIV OF MARYLAND, COLLEGE PARK | Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential | Active |
2021 | R21 | CA251015 | RFA-CA-20-017 | STILL, AMANDA NICOLE HAYMOND | GEORGE MASON UNIVERSITY | New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions | Active |
2021 | R43 | CA261362 | PAR-18-303 | ALLEN, JEFFREY KEITH | TUMORGEN, INC. | Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. | Active |
2023 | R61 | CA278459 | RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer | Active |
2022 | R33 | CA267221 | CA21-004 | NORMAN, THOMAS MAXWELL | SLOAN-KETTERING INST CAN RESEARCH | Systematic characterization of cancer variants using single-cell functional genomics | Active |
2022 | R21 | CA267222 | CA21-003 | LEE, HAKHO | MASSACHUSETTS GENERAL HOSPITAL | 3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids | Active |
2021 | R21 | CA255894 | RFA-CA-20-017 | XIAO, HAN | RICE UNIVERSITY | Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion | Active |
2022 | R21 | CA257942 | RFA-CA-21-003 | GIBBS, SUMMER LYNNE | OREGON HEALTH & SCIENCE UNIVERSITY | A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors | Active |
2022 | R21 | CA257980 | CA21-003 | BELCHER, ANGELA M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineage | Active |
2021 | R21 | CA256081 | RFA-CA-20-017 | SWAGER, TIMOTHY M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation | Active |
2020 | R33 | CA240191 | RFA-CA-19-020 | RECHT, MICHAEL | PALO ALTO RESEARCH CENTER | High-Throughput Screening Platform for Cancer Drug Discovery | Active |
2023 | R61 | CA281795 | RFA-CA-22-001 | CAMPAGNOLA, PAUL J | UNIVERSITY OF WISCONSIN-MADISON | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. | Active |
2022 | R33 | CA267226 | CA21-004 | DRAKE, RICHARD R | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids | Active |
2021 | R21 | CA256082 | RFA-CA-20-017 | BAR-PELED, LIRON | MASSACHUSETTS GENERAL HOSPITAL | Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors | Active |
2023 | R33 | CA278510 | RFA-CA-22-004 | DUNCAVAGE, ERIC J | WASHINGTON UNIVERSITY | A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer | Active |
2022 | R21 | CA267260 | CA21-003 | ARMITAGE, BRUCE A | CARNEGIE-MELLON UNIVERSITY | Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA | Active |
2021 | R21 | CA258019 | RFA-CA-20-017 | CHEN, KAI | UNIVERSITY OF SOUTHERN CALIFORNIA | Novel Bisphosphonate PET Probes for Myeloma Bone Disease | Active |
2022 | R33 | CA259451 | RFA-CA-21-004 | NAEGLE, KRISTEN M | UNIVERSITY OF VIRGINIA | A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides | Active |
2022 | R21 | CA257816 | CA21-003 | COUNTER, CHRISTOPHER M | DUKE UNIVERSITY | Adapting K-MDS to detect KRAS-mutant ctDNA | Active |
2021 | R33 | CA247700 | RFA-CA-20-018 | JI, HANLEE P | STANFORD UNIVERSITY | Multimodal iterative sequencing of cancer genomes and single tumor cells | Active |
2023 | R33 | CA277820 | RFA-CA-22-002 | WEISSLEDER MD PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL | Bioorthogonal probe development for highly parallel in vivo imaging | Active |
2022 | R33 | CA261696 | CA21-004 | MERAJVER, SOFIA DIANA | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence | Active |
2021 | R33 | CA247744 | RFA-CA-20-018 | GARTNER, ZEV JORDAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | Universal Sample Multiplexing for Single Cell Analysis | Active |
2023 | R33 | CA278393 | RFA-CA-22-002 | VAN GALEN, PETER | BRIGHAM AND WOMEN'S HOSPITAL | Clonal analysis of cancer by mitochondrial DNA barcoding | Active |
2022 | R33 | CA269015 | CA21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY | Accessible high-throughput single-cell genome sequencing | Active |
2021 | R33 | CA251006 | RFA-CA-20-020 | HAUN, JERED BRACKSTON | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic tumor tissue processing platform for single cell diagnostics | Active |
2023 | R33 | CA278551 | RFA-CA-22-002 | ISSADORE, DAVID AARON | UNIVERSITY OF PENNSYLVANIA | Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma | Active |
2022 | R33 | CA258012 | CA21-004 | KARGINOV, ANDREI V | UNIVERSITY OF ILLINOIS AT CHICAGO | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo | Active |
2021 | R33 | CA255893 | RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON | Joint receptor and protein expression immunophenotyping through split-pool barcoding | Active |
2023 | R33 | CA278544 | RFA-CA-22-004 | LEVENSON, RICHARD M | UNIVERSITY OF CALIFORNIA AT DAVIS | CoreView and FIBI for rapid-onsite evaluation and molecular profiling of core-needle breast biopsies. | Active |
2022 | R21 | CA269091 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions | Active |
2021 | R33 | CA256102 | RFA-CA-20-018 | GREENBERG, JOEL | DUKE UNIVERSITY | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | Active |
2023 | R61 | CA281807 | RFA-CA-22-001 | HACOHEN, NIR | BROAD INSTITUTE, INC. | Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries | Active |
2022 | R33 | CA269094 | CA21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2022 | R21 | CA272014 | RFA-CA-21-003 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | Active |